Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NBMX - National Boston Medical (was FGRX) -- Ignore unavailable to you. Want to Upgrade?

To: WM. S. TREADWAY who wrote (1213)	7/28/1999 4:49:00 PM
From: Pete NY	Respond to of 1286

Yes, from the information that I have the Form-10 is supposed to be filed on Monday (8/2/99). People keep posting that the date is August 1st, but that is a Sunday. Looking for a great run at the close of this week and through next week. Stay tuned.

To: WM. S. TREADWAY who wrote (1213)	8/2/1999 9:39:00 PM
From: Pete NY	Read Replies (1) \| Respond to of 1286

News today on new CFO: techstocks.com SOURCE: National Boston Medical, Inc. National Boston Medical, Inc. Appoints New CFO TAUNTON, Mass., Aug. 2 /PRNewswire/ -- National Boston Medical, Inc. (OTC Bulletin Board: NBMX - news) announced today it has appointed Barry McFarland as Chief Financial Officer. Mr. McFarland has served as interim CFO through Management Resources, Inc. for National Boston Medical, Inc. since March of this year. Mr. McFarland, age 48, has over twenty-five years of experience in corporate finance and general management. Most recently he served as CFO and Vice President of Operations for NuWay Corporation, a start-up manufacturer of moist tissue products for retail distribution. He was previously Vice President of Finance and Chief Operating Officer for International Treasury Systems, Inc., a software development and systems integrator of foreign exchange trading systems. He also served as Division Controller and Director of Finance for two divisions of Computervision Corporation, each having revenues in excess of $100 million and as a Corporate Senior Financial Analyst for the Gillette Company. Mr. McFarland holds a B.S. Degree in Finance, Cum Laude, from Boston College. Daniel Hoyng, CEO of National Boston Medical, Inc. stated, ''Barry has provided a real sense of financial direction to National Boston Medical, Inc. and has played a critical role if the preparation of our Form 10, which will be filed on time, as previously stated, by the end of this week. His qualities will allow National Boston Medical, Inc. to set a very high standard in its preparation and presentation of its financial position.'' National Boston Medical, Inc. distributes, manufactures, and designs infection-reducing medical and dental instruments and personal care products engineered to enhance public health and hygiene. Their products include Safeshield(TM) antimicrobial skin protectant cream, the Bontempi(TM) line of surgical and dental instruments, and the Backstroke® Back Massager. For investor information contact Global Development Advisors at 561-694-9425. The statements in this release regarding future results of operation are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although the company believes the expectations reflected in such forward-looking statements are based on reliable assumptions, it can give no assurance that its expectations will be obtained. The company disclaims any intent or obligation to update these forward-looking statements.